Latest Vaccine Development News

Immuron Limited reports topline results from a Uniformed Services University trial of a third-party ETEC product that missed its primary endpoint, reaffirming commitment to its established Travelan dosing ahead of FDA discussions.

New Zealand King Salmon reported a $20.8 million net loss for the half year ending July 2025, driven by biological setbacks and reduced harvests. Despite this, the company maintains a strong balance sheet and is advancing its Blue Endeavour pilot farm and growth initiatives.

AnteoTech Ltd reports a strong FY2025 with doubled sales revenue, strategic partnerships, and key product milestones in battery materials and life sciences diagnostics.

Noxopharm has initiated its HERACLES clinical trial for SOF-SKN, marking a key milestone for its Sofra platform, while deepening partnerships and actively seeking new funding to sustain development.